Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats

Toxicology and Applied Pharmacology

Volumn 208, Issue 1, 2005, Pages 29-36

  Kim, Soon Ja ^a   Bok, Song Hae ^b   Lee, Sangku ^c   Kim, Hye Jin ^a   Lee, Mi Kyung ^a   Park, Yong Bok ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Konyang University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

3,4 dihydroxyphenylpropionic (L serine methyl ester) amide (E030) and 3,4 dihydroxyphenylpropionic (L aspartic acid) amide (E076); Hypercholesterolemia; Lipid lowering

Indexed keywords

AMIDE; CHOLESTEROL ACYLTRANSFERASE; CLOFIBRATE; DIHYDROCAFFEIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYPOCHOLESTEROLEMIC AGENT; STEROL;

ARTICLE; ATHEROGENESIS; BODY WEIGHT; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FOOD INTAKE; LIVER TOXICITY; NONHUMAN; RAT; WEIGHT GAIN;

ALANINE TRANSAMINASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; ASPARTATE AMINOTRANSFERASES; ASPARTIC ACID; CAFFEIC ACIDS; CHOLESTEROL; CHOLESTEROL, DIETARY; CINNAMATES; CLOFIBRATE; FECES; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERCHOLESTEROLEMIA; LIPIDS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; SERINE; STEROL O-ACYLTRANSFERASE; TRIGLYCERIDES;

EID: 24744466273     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2005.01.012     Document Type: Article

References (44)

1. A.W. Alberts Discovery, biochemistry and biology of lovastatin Am. J. Cardiol. 62 1988 10 15
2. A.W. Alberts, J. Chen, and G. Kuron Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent Proc. Natl. Acad. 77 1980 3957 3961
3. C.C. Allain, L.S. Poon, C.S. Chan, W. Richmond, and P.C. Fu Enzymatic determination of total serum cholesterol Clin. Chem. 20 1974 470 475
4. American Institute of Nutrition Report of the American Institute of Nutrition. Ad Hoc committee on standards for nutritional studies J. Nutr. 107 1977 1340 1348
5. American Institute of Nutrition Report of Ad Hoc committee on standards for nutritional studies J. Nutr. 110 1980 1717 1726
6. D. Amin, S.K. Gustafson, and J.M. Weinacht RG 12561 (dalvastatin): a novel synthetic inhibitor of HMG-CoA reductase and cholesterol-lowering agent Pharmacology 47 1993 13 22
7. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
8. J. Chalas, C. Claise, M. Edese, C. Messaoudi, L. Vergnes, and A. Abella Effect of ethyl esterification of phenolic acids on low-density lipoprotein oxidation Biomed. Pharmacother. 55 2001 54 60
9. F. Czubayko, B. Beumers, D. Lutigohann, and K. Bergmann A simplified micro-method for quantitation of fecal excretion for neutral and acidic sterols for outpatient studies in humans J. Lipid Res. 32 1992 1861 1867
10. S.K. Erickson, M.A. Schrewsbery, C. Brooks, and D.J. Meyer Rat liver acyl-coenzyme A: cholesterol acyltransferase: its regulation in vivo and some of properties in vitro J. Lipid Res. 21 1980 930 941
11. H. Esterbauer, G. Jurgens, O. Quehenberger, and E. Koller Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes J. Lipid Res. 28 1987 495 509
12. J. Folch, M. Lees, and G.H. Sloane-Stanley A simple method for isolation and purification of total lipids from animal tissues J. Biol. Chem. 226 1957 497 509
13. M. Garcia-Gonzalex, J.L. Segovia, and M.J. Ake jan Dro Homeostatic restoration of microsomal lipids and enzyme changes in HMG-CoA reductase and acyl-CoA: cholesterol acyltransferase in chick liver Mol. Cell. Biochem. 115 1992 173 178
14. K.F. Gey, G.B. Brubacher, and H.B. Stahelin Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer Am. J. Clin. Nutr. 45 1987 1368 1377
15. P.J. Gillies, K.A. Rathgeb, M.A. Perri, and C.S. Robinson Regulation of acyl-CoA: cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: role of a cholesterol substrate pool Exp. Mol. Pathol. 44 1986 320 339
16. A.M. Gotto Triglyceride as a risk factor for coronary artery disease Am. J. Cardiol. 82 1988 22 25
17. W.M. Grogan, M.L. Bailey, D.M. Heuman, and Z.R. Vlahcevic Effects of perturbances in hepatic free and esterified cholesterol pools on bile acid synthesis, cholesterol 7 alpha-hydroxylase, HMG-CoA reductase, Acyl-CoA: cholesterol acyltransferase and cytosolic cholesteryl ester hydrolase Lipids 26 1991 907 914
18. R.J. Havel, and Rapaport Management of primary hyperlipidemia N. Engl. J. Med. 332 1995 1491 1498
19. M.G. Hertog, P.C. Hollman, K.B. Katan, and D. Kromhout Intake on potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands Nutr. Cancer 20 1993 20 29
20. M.G. Hertog, D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Menotti, S. Nedeljikovic, M. Pekkarinen, B.S. Simic, H. Toshima, E.J.M. Feskens, P.C. Hollman, and M.B. Katan Flavonoid intake and long term risk of coronary heart disease and cancer in the seven countries study Arch. Intern. Med. 155 1995 381 386
21. F.H. Hulcher, and W.H. Oleson Simplified spectrophotometric assay for microsomal3 hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A J. Lipid Res. 14 1973 625 631
22. T. Ishii, T. Hiroi, and J.R. Thomas Feruloylated xyloglucan and p-coumaroyl arabinoxylan oligosaccharides from bamboo shoot cell-walls Phytochemistry 29 1990 1999 2003
23. H. Iwahashi, T. Ishii, R. Sugata, and R. Kido The effects of caffeic acid and its related catechols on hydroxyl radical formation by 3-hydroxyanthranilic acid, ferric chloride, and hydrogen peroxide Arch. Biochem. Biophys. 276 1990 242 247
24. S.R. Jolly, W.J. Kane, M.B. Bailie, G.D. Abrams, and B.R. Lucchesi Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase Circ. Res. 54 1984 277 285
25. S.M. Kern, R.N. Bennett, P.W. Needs, F.A. Mellon, P.A. Kroon, and M.T. Garcia-Conesa Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium caco-2 cells J. Agric. Food Chem. 31 2003 7884 7891
26. E.E. Largis, C.H. Wang, V.G. De Vries, and S.A. Schaffer A novel inhibitor of ACAT catalyzed cholesterol esterification and cholesterol absorption J. Lipid Res. 30 1989 681 690
27. J.-S. Lee, M.-S. Choi, S.-M. Jeon, T.-S. Jeong, Y.B. Park, M.-K. Lee, and S.-H. Bok Lipid-lowering and antioxidative activities of 3,4-di(OH)-cinnamate and 3,4-di(OH)-hydrocinnamate in cholesterol-fed rats Clin. Chim. Acta 314 2001 221 229
28. S.K. Lee, J.-M. Han, H. Kim, E. Kim, T.-S. Jeong, W.S. Lee, and K.-H. Cho Synthesis of cinnamic acid derivatives and their inhibitory effects on LDL-oxidation, acyl-CoA:cholesterol acyltransferase-1 and -2 activity, and decrease of HDL-particle size Bioorg. Med. Chem. 14 2004 4677 4681
29. J.R. Li, R.J. Holets, and B.A. Kottke Effect of probucol on cholesterol metabolism in the rat Atherosclerosis 36 1980 559 565
30. M.W. McGowan, J.D. Artiss, D.R. Strandbergh, and B. Zak A peroxidase-coupled method for the colorimetric determination of serum triglycerides Clin. Chem. 29 1983 538 542
31. J.C. Michael, and A.M. Ian Enzymatic determination of 3α-, 7α- and 12α hydroxyl groups of fecal bile salts Clin. Chem. 26 1980 1298 1300
32. M. Nardini, M. D'Aquino, G. Tomassi, V. Gentili, M. Di Felice, and C. Scaccini Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives Free Radical Biol. Med. 19 1995 541 552
33. T.N. Patil, and M. Srinivasan Hypocholesterolemic effect of curcumin in induced hypercholesterolemic rats Indian J. Exp. Biol. 9 1971 167 169
34. K. Prased, J. Kalra, and B. Bharswaj Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery Am. Heart J. 123 1992 37 45
35. S. Reitman, and S. Frankel A colorimetric method for the determination of serum glutamic oxaloacetic and glutamic pyruvic transaminase Am. J. Clin. Pathol. 2 1957 56 63
36. R. Ross The pathogenesis of atherosclerosis: a perspective for 1990s Nature 362 1993 801 809
37. C. Sgro, and A. Escousse Side effects of fibrates (except liver and muscle) Therapie 46 1991 351 354
38. D.J. Shapiro, J.L. Nordstorm, J.J. Mitschelen, V.W. Rodwell, and R.T. Schimke Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts Biochim. Biophy. Acta 370 1974 369 377
39. R.D. Subba, S.N. Chandra, N. Satyanarayana, and M. Srinivasan Effect of curcumin on serum and liver cholesterol levels in the rat J. Nutr. 100 1970 1307 1316
40. T. Tanaka, T. Kojima, T. Kawamori, A. Wang, M. Suzui, and K. Okamoto Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferrulic acids Carcinogenesis 14 1993 1321 1325
41. R.G. Waenic, and J.J. Albers A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating a high density lipoprotein cholesterol J. Lipid Res. 19 1978 65 76
42. G.F. Watta, and S.B. Dimmitt Fibrate, dyslipoproteinemia and cardiovascular disease Curr. Opin. Lipidol. 10 1999 561 574
43. R.W. Wissler Theories and mew horizons in the pathogenesis of atherisclerosis and the mechanisms of clinical effects Arch. Pathol. Lab. Med. 116 1992 1281 1291
44. J. Yamada, and Y. Tomita Antimutagenic activity of caffeic acid and related compounds Biosci. Biotechnol. Biochem. 60 1996 328 329